4D Molecular Therapeutics Inc. (FDMT)
NASDAQ: FDMTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 12.59 0.00%
FDMT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $695.52M
- EPS (TTM)
- -$2.63
- Dividend yield
- None
- 52-week range
- 6.96 – 16.93
- Day range
- 12.19 – 12.90
- Volume / Avg
- 585.35K / 924.05K
- Beta
- —
- Shares outstanding
- 55.24M
- Next earnings
- Nov 10, 2026
52-week range
FDMT stock today
4D Molecular Therapeutics (FDMT) closed at $12.59 on Oct 7, up 0.24% (+$0.03), versus the S&P 500's 0.22% decline. Shares are 25.6% below their 52-week high of $16.93 and 80.9% above the 52-week low of $6.96, in the middle of the past year's range. 4D Molecular Therapeutics has posted a net loss over the last twelve months (EPS of -$2.63), so its P/E ratio is not meaningful.
4D Molecular Therapeutics's next earnings report is expected on Nov 10, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About 4D Molecular Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2020
Earnings
Earnings history- Next report
- Nov 10, 2026
4D Molecular Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PRMEPrime Medicine Inc. | 3.90 | +11.43% | $707.37M | vs FDMT |
| AURAAura Biosciences Inc. | 6.46 | +4.70% | $669.93M | vs FDMT |
| SLDBSolid Biosciences Inc. | 6.85 | -1.01% | $734.49M | vs FDMT |
| ATTOAttovia Therapeutics Inc. | 16.42 | -6.17% | $749.59M | vs FDMT |
| CADLCandel Therapeutics Inc. | 9.82 | -0.51% | $751.41M | vs FDMT |
| PROKProKidney Corp. Class A | 1.57 | -1.88% | $626.72M | vs FDMT |
| DNAGinkgo Bioworks Holdings Inc. Class A | 11.46 | -7.65% | $771.73M | vs FDMT |
| DBVTDBV Technologies S.A. ADR | 9.77 | -2.10% | $614.03M | vs FDMT |
Indexes, lists and sector
Largest Health Care stocks
4D Molecular Therapeutics stock FAQ
What is 4D Molecular Therapeutics's stock price today?
FDMT last traded at $12.59 as of Oct 7, 4:00 PM EDT, up 0.24% on the day. Prices are delayed at least 15 minutes.
When is 4D Molecular Therapeutics's next earnings date?
4D Molecular Therapeutics is expected to report earnings on Tuesday, November 10, 2026.
What is the FDMT 52-week high?
The 52-week high for FDMT is $16.93 and the 52-week low is $6.96. The stock is currently 25.6% below its high.